Kiyoaki Kobayashi
EisaiTokyo, Japan
1415 RESULTS
EisaiTokyo, Japan
PAPER Soto-Mercado V, Mendivil-Perez M, Jimenez-Del-Rio M, Velez-Pardo C
Huber Heights, United States
COMMENT Much has been said on aducanumab already and, as in any scientific debate, opinions differ widely. Unfortunately, as was evident from the FDA hearing, the debate has become polarized, as if it were politics. This is never beneficial to any debate. This ...
MUTATIONS 227077809 GRCh37 (105) rs75733498 C T PSEN2 Exon 8 Point, Silent Coding Unknown. Unknown, but associated with increased glucose metabolism in the bilateral fronto-temporo-parietal cortices. P287P Alzheimer's Disease: Unclear Pathogenicity This ...
MUTATIONS 73686944 GRCh37 (105) rs7523 G A PSEN1 3' UTR Point Non-Coding Unknown Unknown, associated with increased thickness in the inferior frontal and orbitofrontal cortices, and basal ganglia c.*947G>A Alzheimer's Disease: Unclear Pathogenicity ...
Amsterdam UMC Dept. of Neurology/Alzheimer Center and Brain Research Center Amsterdam
London, United Kingdom
PAPER Senkevich K, Bandres-Ciga S, Gan-Or Z, Krohn L, International Parkinson's Disease Genomics Consortium (IPDGC)
PAPER Malik N, Kornelsen R, McCormick S, Colpo N, Merkens H, Bendre S, Benard F, Sossi V, Schirrmacher R, Schaffer P
PAPER Kong G, Ellul S, Narayana VK, Kanojia K, Ha HT, Li S, Renoir T, Cao KL, Hannan AJ
PAPER Robbins R, DiClemente RJ, Troxel AB, Jean-Louis G, Butler M, Rapoport DM, Czeisler CA
GRANT Monday, November 30, 2020- 20:45 Michigan Center for Contextual Factors in Alzheimer’s Disease Up to $30,000 direct costs for a relevant research proposal, pending NIA approval. Completed applications should be emailed as a single pdf attachment to mccfad ...
PAPER Darrow JA, Calabro A, Gannon S, Orusakwe A, Esquivel R, Traynham CJ, Rao A, Gulyani S, Khingelova K, Bandeen-Roche K, Albert M, Moghekar A